FEBBO WILLIAM J 4
4 · OptimizeRx Corp · Filed Jun 12, 2024
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
FEBBO WILLIAM J
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2024-04-18+28,895→ 582,035 total - Tax Payment
Common Stock
2024-04-18$9.35/sh−782$7,312→ 581,253 total - Exercise/Conversion
Restricted Stock Units
2024-04-18−28,895→ 57,790 total→ Common (28,895 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The Reporting Person's prior holdings were previously inadvertently overstated by four shares.
- [F3]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F4]On April 18, 2023, the Reporting Person was granted 86,685 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.